Epstein Secrets

.62 1.71 NA NN 196.1 11311 51013 510.6 (11391 13.11 et» 0331 lab il laTii 13541 Ot01 22595 3.5 DU 23.7 41501 O.% I17.1) (1611 Laine 91.4711.1 11374.2 51.761.1 51./C0.9 6123 5200 5010 6431 4436 1151.2 I.101.1 1.175.5 1145 oto 104 5730 1959 149.7 55/6 (433.1 134

sh balance as of the Valuation Dale includes the cash proceeds from the most recent Series 5 round of financing (of approximately 539.5 million from IP Morgan Private Equity). which dosed recent to the Valuation Date. As of For the fiscal }emending December 31, 2008 2009 2010 Val.Dale 2011 2012 2013 2014 2015

.62 1.71 NA NN 196.1 11311 51013 510.6 (11391 13.11 et» 0331 lab il laTii 13541 Ot01 22595 3.5 DU 23.7 41501 O.% I17.1) (1611 Laine 91.4711.1 11374.2 51.761.1 51./C0.9 6123 5200 5010 6431 4436 1151.2 I.101.1 1.175.5 1145 oto 104 5730 1959 149.7 55/6 (433.1 134

sh balance as of the Valuation Dale includes the cash proceeds from the most recent Series 5 round of financing (of approximately 539.5 million from IP Morgan Private Equity). which dosed recent to the Valuation Date. As of For the fiscal }emending December 31, 2008 2009 2010 Val.Dale 2011 2012 2013 2014 2015

.62 1.71 NA NN 196.1 11311 51013 510.6 (11391 13.11 et» 0331 lab il laTii 13541 Ot01 22595 3.5 DU 23.7 41501 O.% I17.1) (1611 Laine 91.4711.1 11374.2 51.761.1 51./C0.9 6123 5200 5010 6431 4436 1151.2 I.101.1 1.175.5 1145 oto 104 5730 1959 149.7 55/6 (433.1 134

sh balance as of the Valuation Dale includes the cash proceeds from the most recent Series 5 round of financing (of approximately 539.5 million from IP Morgan Private Equity). which dosed recent to the Valuation Date. As of For the fiscal }emending December 31, 2008 2009 2010 Val.Dale 2011 2012 2013 2014 2015